Main Menu

New: Our latest case study on qFibrosis' role in the successful development of Rezdiffra

Read here

News

HistoIndex Charts New Course in Liver Disease Innovation: Announces Pivotal Changes to Scientific Advisory Board

July 1, 2024 Press Release

Madrigal Pharmaceuticals Announces New Data from the Phase 3 MAESTRO-NASH Study of Rezdiffra™ (resmetirom) Presented at the EASL Congress

June 6, 2024 Media Coverage

HistoIndex to Showcase Groundbreaking AI-powered Stain-free Digital Pathology Advances with 8 Accepted Abstracts at EASL Congress 2024

June 3, 2024 Press Release

Sagimet Biosciences Announces Positive Topline Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 NASH

January 22, 2024 Media Coverage

Histoindex’s tissue imaging tech demonstrates consistent results in measuring fibrosis

August 11, 2023 Media Coverage

How AI is shaping clinical research and trials

July 21, 2023 Media Coverage

Madrigal Pharmaceuticals Presents Phase 3 MAESTRO-NASH Data During the Opening General Session of the EASL Congress™

June 22, 2023 Media Coverage

HistoIndex Presents Advancements in AI-powered Stain-free Tissue Imaging for NASH Clinical Trials at EASL Congress 2023

June 21, 2023 Press Release

TANDEM study shows potential of HistoIndex SHG/TPE imaging and AI-based technology in evaluating the effects of combination therapy for NASH

June 15, 2023 Press Release

HistoIndex SHG/TPE imaging and AI-based technology reveals dose-dependent effectiveness of Tropifexor for NASH patients in Nature Medicine

June 15, 2023 Press Release

HistoIndex embarks on partnership with VCU’s Stravitz-Sanyal Institute for Liver Disease and Metabolic Health in the study of liver diseases

April 10, 2023 Press Release

Appointment of Dr. David John Jeans CBE as HistoIndex’s Non-Executive Chairman

January 9, 2023 Press Release

HistoIndex Stain-free AI-DP Reveals Treatment-induced Zonal Regression of Fibrosis Colocalized with Reduction in Steatosis & Hepatocyte Ballooning in FLIGHT-FXR NASH Clinical Trial

July 29, 2022 Press Release

HistoIndex and Global Liver Experts Advance Stain-free AI Quantification of Hepatocyte Ballooning as a Reproducible Approach and Potential Endpoint for NASH Clinical Trials

March 9, 2022 Press Release

HistoIndex and Galecto to Collaborate on Galecto’s Phase 2a MYLOX-1 Clinical Trial to Advance Myelofibrosis Assessment with AI-based Stain-free Digital Pathology

October 20, 2021 Press Release

HistoIndex’s Stain-free AI-based Digital Pathology Incorporated as Secondary and Exploratory Efficacy Endpoints in Sagimet’s NASH FASCINATE-2 Phase 2b Clinical Trial

August 18, 2021 Press Release

HistoIndex’s AI-Based Digital Pathology Indicates Concomitant Histological Improvements in Liver Fat and Fibrosis in Nonalcoholic Steatohepatitis (NASH) Patients Treated with Tropifexor Compared with Placebo

June 25, 2021 Press Release

Singapore: A Myriad of Biotech Financing Strategies

June 10, 2021 Media Coverage

A proprietary biophotonics technology and platform for stain-free AI-based digital pathology

February 16, 2021 Media Coverage

HistoIndex Explores the Clinical Utility of Stain-free AI Digital Pathology Platform in 388 Patients with Triple-Negative Breast Cancer (TNBC)

January 24, 2021 Press Release

Behind the Success of Singapore’s Healthcare and Biomedical Startups

November 13, 2020 Media Coverage

HistoIndex’s AI-based Digital Pathology Platform: A Validated Quantification Tool Recommended in the Guidelines for the Prevention and Treatment of Chronic Hepatitis B in China

May 24, 2020 Press Release

qFIBS Demonstrates Suitability for Nonalcoholic Steatohepatitis (NASH) Assessment in Clinical Trials and Patient Care with Full Quantification of All Histopathological Features

November 9, 2019 Press Release

HistoIndex Announces Global Partnerships to Expand AI-Based Digital Pathology Platform as a Drug Discovery Tool in Preclinical Studies for Nonalcoholic Steatohepatitis (NASH)

October 26, 2019 Press Release

LITMUS – Progress towards diagnosing and better treating liver disease

August 20, 2019 Press Release

HistoIndex and ILBS Launch Centre of Excellence in New Delhi for Advanced Diagnostics and Clinical Research on Nonalcoholic Steatohepatitis (NASH)

August 7, 2019 Press Release

SGH develops test that achieves consistency, accuracy in measuring the extent of fatty liver

April 25, 2019 Media Coverage

HistoIndex’s Second Harmonic Generation (SHG) Technology: A Potentially Important Tool Used In Madrigal’s Phase 2 Nonalcoholic Steatohepatitis (NASH) Clinical Trial

December 23, 2018 Press Release

Southeast Asia’s largest medical device maker ready to fund ‘category disruptor’ start-ups

June 21, 2018 Media Coverage

A Worldwide Effort to Defeat Nonalcoholic Steatohepatitis (NASH)

June 8, 2018 Press Release

HistoIndex and CymaBay Therapeutics Team Up to Advance NASH Drug Development

May 18, 2018 Press Release

Forging New Paths In Cancer Diagnostics

January 26, 2018 Media Coverage

HistoIndex Receives Frost & Sullivan 2017 Asia-Pacific Best Practices Award for Innovative Diagnostics in the Area of Nonalcoholic Steatohepatitis (NASH)

October 4, 2017 Press Release

Exposing A Silent Killer: Liver Disease

September 1, 2017 Media Coverage

Building ties in pharma industry ‘just like courtship’

August 9, 2017 Media Coverage

Beautiful Science

December 9, 2016 Media Coverage

Leading The Disruption Of Tissue Imaging

July 22, 2016 Media Coverage

Zicom Group invests in Singapore growth phase medtech Histoindex

June 11, 2015 Media Coverage

HistoIndex sets new standards in fibrosis diagnosis

March 14, 2012 Media Coverage

Connect with us

Linkedin Youtube

Pages

Locations

Singapore HQ
Teletech Park
20 Science Park Road, #01-26/27
Singapore 117674

UK Branch
Queen Elizabeth University Hospital,
Imaging Centre of Excellence, L3-18, Langlands Drive, Glasgow G51 4LB,
United Kingdom

China Subsidiary Office
Room 1001, Building 10
No. 188 Binkang Road, Hangzhou
Zhejiang 310051, China

©2024 Histoindex Pte Ltd. All Rights Reserved. All logos and trademarks are the property of HistoIndex or their respective owners.